Literature DB >> 15715193

The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant.

A M Sadowska1, F J van Overveld, D Górecka, A Zdral, M Filewska, U A Demkow, C Luyten, E Saenen, J Zielinski, W A De Backer.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is accompanied by both airway and systemic inflammation and by oxidative stress. This study aimed to characterise the relationship between oxidative stress and inflammatory components in induced sputum and blood. MATERIAL &
METHODS: We studied blood and sputum samples from stable COPD patients (mean FEV1 60.5+/-7.5% predicted) at baseline (no treatment) and after 10 weeks treatment with either inhaled steroid, fluticasone propionate (FP) (1000 microg/d) or 10 weeks treatment with N-acetylcysteine (600mg/d) (NAC). We assessed the inflammatory markers (IL-8, ECP, sICAM-1, NE) in sputum and serum and we compared them with blood markers of oxidative stress (SOD, GPx, TEAC, albumin, vitamin E and A).
RESULTS: At baseline blood sICAM-1 correlated with IL-8 levels (P<0.01, r = 0.62) and negatively with GPx (P<0.01, r = -0.63) and with TEAC (P<0.05, r = -0.53). TEAC correlated positively with GPx (P<0.01, r = 0.70). Correlation between sICAM and IL-8 disappeared after NAC treatment. The correlation between sICAM and GPx disappeared after FP treatment. The correlation between TEAC and GPx was maintained after both NAC and FP.
CONCLUSIONS: The relationship between markers of inflammation, adhesion and antioxidant capacity is significantly modulated by treatment with N-acetylcysteine or inhaled corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715193     DOI: 10.1016/j.rmed.2004.07.005

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  18 in total

Review 1.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

2.  Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.

Authors:  Tanyalak Parimon; Jason W Chien; Chris L Bryson; Mary B McDonell; Edmunds M Udris; David H Au
Journal:  Am J Respir Crit Care Med       Date:  2006-12-21       Impact factor: 21.405

3.  Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers.

Authors:  Michael E Nicks; Maureen M O'Brien; Russell P Bowler
Journal:  COPD       Date:  2011-06-01       Impact factor: 2.409

Review 4.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

5.  Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice.

Authors:  Anna A Shvedova; Elena R Kisin; Ashley R Murray; Olga Gorelik; Sivaram Arepalli; Vincent Castranova; Shih-Hong Young; Fei Gao; Yulia Y Tyurina; Tim D Oury; Valerian E Kagan
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-27       Impact factor: 4.219

6.  Oxidative Stress: A Potential Therapeutic Target in Placental Malaria.

Authors:  Demba Sarr; Caitlin A Cooper; Tara C Bracken; Omar Martinez-Uribe; Tamas Nagy; Julie M Moore
Journal:  Immunohorizons       Date:  2017-06-01

Review 7.  Role of mucolytics in the management of COPD.

Authors:  Phillippa J Poole
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 8.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 9.  The role for N-acetylcysteine in the management of COPD.

Authors:  P N R Dekhuijzen; W J C van Beurden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice.

Authors:  Umesh C S Yadav; Kota V Ramana; Leopoldo Aguilera-Aguirre; Istvan Boldogh; Hamid A Boulares; Satish K Srivastava
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.